Research programme: anti-CD146 antibodies - Chinese Academy of Sciences/MicroConstants China

Drug Profile

Research programme: anti-CD146 antibodies - Chinese Academy of Sciences/MicroConstants China

Alternative Names: AA98

Latest Information Update: 08 Feb 2016

Price : $50

At a glance

  • Originator Chinese Academy of Sciences
  • Developer Chinese Academy of Sciences; MicroConstants China
  • Class Antibodies
  • Mechanism of Action Cell adhesion molecule inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Age-related macular degeneration; Cancer; Multiple sclerosis

Most Recent Events

  • 29 Jan 2015 AA98 antibody drug candidates licensed to MicroConstants China worldwide
  • 29 Jan 2015 Preclinical trials in Age-related macular degeneration in China (unspecified route)
  • 29 Jan 2015 Preclinical trials in Cancer in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top